|
Market Closed -
Nasdaq
01:30:00 19/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.3119 USD | -6.48% |
|
-2.65% | -68.81% |
| 08:21am | TScan Therapeutics, Inc.(NasdaqGM:TCRX) dropped from S&P Global BMI Index | CI |
| 03/09 | Needham Downgrades TScan Therapeutics to Hold From Buy | MT |
| Market Cap | 2.11Cr 1.84Cr 1.74Cr 1.58Cr 2.96Cr 202.85Cr 2.97Cr 21Cr 8.05Cr 103.13Cr 7.94Cr 7.77Cr 331.84Cr | P/E 2026 * |
-0.39x | P/E 2027 * | -0.52x |
|---|---|---|---|---|---|
| Enterprise Value | -7.77Cr -6.78Cr -6.4Cr -5.81Cr -11Cr -745.83Cr -11Cr -77Cr -30Cr -379.19Cr -29Cr -29Cr -1.22TCr | EV / Sales 2026 * |
-17.3x | EV / Sales 2027 * | -16.4x |
| Free-Float |
93.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TCRX | Delayed | |
CBOE
| TCRX | Real-time |
Last Transcript: TScan Therapeutics, Inc.
| 1 day | -6.48% | ||
| 1 week | -2.65% | ||
| Current month | -57.26% | ||
| 1 month | -59.82% | ||
| 3 months | -66.10% | ||
| 6 months | -70.01% | ||
| Current year | -68.81% |
| 1 week | 0.29 |  | 0.36 |
| 1 month | 0.29 | | 0.81 |
| Current year | 0.29 | | 1.47 |
| 1 year | 0.29 | | 2.57 |
| 3 years | 0.29 | | 9.69 |
| 5 years | 0.29 | | 9.69 |
| 10 years | 0.29 | | 14.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin MacBeath
CEO | Chief Executive Officer | 56 | 28/03/2023 |
Dawn Pinchasik
CTO | Chief Tech/Sci/R&D Officer | - | 06/02/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Katina Dorton
BRD | Director/Board Member | 68 | 23/03/2021 |
Gavin MacBeath
BRD | Director/Board Member | 56 | 24/05/2023 |
Stephen Biggar
CHM | Chairman | 55 | 12/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/05/26 | Free | Director | 67,000 | 0.1200% | ||
| 20/05/26 | Free | Director | 67,000 | 0.1200% | ||
| 20/05/26 | Free | Director | 67,000 | 0.1200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.48% | -2.65% | -82.58% | -89.02% | 2.11Cr | |
| -0.31% | +5.79% | +47.13% | +99.53% | 7.09TCr | |
| -0.25% | +0.28% | +37.86% | +83.74% | 6.25TCr | |
| +5.26% | +7.86% | +32.24% | +30.06% | 2.63TCr | |
| -3.21% | -7.27% | -17.10% | +370.22% | 2.62TCr | |
| -2.64% | -0.69% | -0.17% | -11.56% | 2.41TCr | |
| -1.11% | +5.91% | +23.44% | -12.19% | 2.07TCr | |
| +2.12% | -5.86% | +161.58% | +333.73% | 1.57TCr | |
| -0.22% | +3.99% | +45.54% | +171.32% | 1.45TCr | |
| +0.73% | +1.71% | -5.51% | +859.68% | 1.42TCr | |
| Average | -0.59% | +1.30% | +24.24% | +183.55% | 2.75TCr | |
| Weighted average by Cap. | -0.08% | +1.49% | +35.26% | +153.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45.05L 39.29L 37.09L 33.68L 63.11L 43Cr 63.38L 4.44Cr 1.71Cr 22Cr 1.69Cr 1.65Cr 71Cr | 32.77L 28.57L 26.98L 24.5L 45.9L 31Cr 46.09L 3.23Cr 1.25Cr 16Cr 1.23Cr 1.2Cr 51Cr |
| Net income | -10Cr -9.14Cr -8.63Cr -7.84Cr -15Cr -1.01TCr -15Cr -103.42Cr -40Cr -511.55Cr -39Cr -39Cr -1.65TCr | -7.91Cr -6.9Cr -6.51Cr -5.91Cr -11Cr -759.02Cr -11Cr -78Cr -30Cr -385.89Cr -30Cr -29Cr -1.24TCr |
| Net Debt | -9.89Cr -8.62Cr -8.14Cr -7.39Cr -14Cr -948.68Cr -14Cr -98Cr -38Cr -482.32Cr -37Cr -36Cr -1.55TCr | -7.48Cr -6.52Cr -6.16Cr -5.59Cr -10Cr -717.32Cr -11Cr -74Cr -28Cr -364.7Cr -28Cr -27Cr -1.17TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | $0.3119 | -6.48% | 11,43,331 |
| 17/26/17 | $0.3335 | +0.76% | 10,96,263 |
| 16/26/16 | $0.3310 | +3.02% | 8,84,124 |
| 15/26/15 | $0.3213 | +4.90% | 6,79,168 |
| 14/26/14 | $0.3063 | -4.40% | 11,03,954 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TCRX Stock
Select your edition
All financial news and data tailored to specific country editions
